Evidence map›Paper›PMID 33138317›Full record

ArticleNutrients2020

Chronological Age Interacts with the Circadian Melatonin Receptor 1B Gene Variation, Determining Fasting Glucose Concentrations in Mediterranean Populations. Additional Analyses on Type-2 Diabetes Risk.

Jose V Sorlí, Rocío Barragán, Oscar Coltell, Olga Portolés, Eva C Pascual, Carolina Ortega-Azorín, José I González, Ramon Estruch, Carmen Saiz, Alejandro Pérez-Fidalgo and 2 more

Abstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jose V SorlíDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0002-0130-2006
Rocío BarragánDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0001-8072-3791
Oscar ColtellCIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-4518-8495
Olga PortolésDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
Eva C PascualDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
Carolina Ortega-AzorínDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0001-6719-9358
José I GonzálezDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
Ramon EstruchCIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0003-1260-4445
Carmen SaizDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
Alejandro Pérez-FidalgoDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
Jose M OrdovasNutrition and Genomics Laboratory, JM-USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA.
Dolores CorellaDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0002-2366-4104

Funding

Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER) CIBER 06/03Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER) PI06/1326Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER) PI13/00728Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER) PI16/00366Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER) PI19/00781Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER) SAF2016-80532-Rthe Fundació La Marató de TV3 538/U/2016the Generalitat Valenciana APOSTD/2019/136the Generalitat Valenciana PROMETEO2017/017the Rei Jaume I Award for Medical Research 2018 PRJI2018the University Jaume I COGRUP/2016/06the University Jaume I P1-1B2013-54the US Department of Agriculture, Agriculture Research Service 8050-51000-098-00D
6 · The paper itself

Abstract

Gene-age interactions have not been systematically investigated on metabolic phenotypes and this modulation will be key for a better understanding of the temporal regulation in nutrigenomics. Taking into account that aging is typically associated with both impairment of the circadian system and a decrease in melatonin secretion, we focused on the melatonin receptor 1B (MTNR1B)-rs10830963 C>G variant that has been associated with fasting glucose concentrations, gestational diabetes, and type-2 diabetes. Therefore, our main aim was to investigate whether the association between the MTNR1B-rs10830963 polymorphism and fasting glucose is age dependent. Our secondary aims were to analyze the polymorphism association with type-2 diabetes and explore the gene-pregnancies interactions on the later type-2 diabetes risk. Three Mediterranean cohorts (

Indexed as

Age FactorsAdolescentAdultAgedAged, 80 and overBlood GlucoseCross-Sectional StudiesDiabetes Mellitus, Type 2FastingFemaleHumansMaleMediterranean RegionMiddle AgedPolymorphism, Single NucleotidePregnancyBlood GlucoseMTNR1B protein, humanReceptor, Melatonin, MT2age-interactionfasting glucosegestational diabetesheterogeneityMediterranean populationmelatonin receptorMTNR1B polymorphismpregnancytype-2 diabeteswomen

Identifiers

PMID33138317
PMCPMC7692445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.